Decreased incidence and severity of graft-versus-host disease in HLA matched and mismatched marrow recipients of cyclosporine and methotrexate
Tollemar, J.; Ringdén, O.; Heimdahl, A.; Lönnqvist, B.; Sundberg, B.
Transplantation Proceedings 20(3 Suppl 3: 470-479
1988
ISSN/ISBN: 0041-1345 PMID: 3291283 Document Number: 319559
Document emailed within 1 workday
Related Documents
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758Mrsić, M.; Labar, B.; Bogdanić, V.; Nemet, D.; Pavletić, Z.; Plavsić, F.; Dobrić, I.; Kastelan, A.; Marusić, M.; Zupancić-Salek, S. 1989: Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias Bone Marrow Transplantation 4(Suppl): 95-96
Przepiorka, D.; Shapiro, S.; Schwinghammer, T.L.; Bloom, E.J.; Rosenfeld, C.S.; Shadduck, R.K.; Venkataramanan, R. 1991: Cyclosporine and methylprednisolone after allogeneic marrow transplantation: association between low cyclosporine concentration and risk of acute graft-versus-host disease Bone Marrow Transplantation 7(6): 461-465
Liem, L.M.; van Noort, J.T.; Goulmy, E. 1996: Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin a Bone Marrow Transplantation 18(1): 73-78
de Gast, G.C.; Beatty, P.G.; Amos, D.; Sullivan, K.; Anderson, J.E.; Thomas, E.D.; Hansen, J.A. 1987: Transfusion effect on graft-versus-host disease and leukemic relapse in HLA-matched bone marrow transplantation Transplantation Proceedings 19(1 Pt 3): 2700
Deeg, H.J.; Spitzer, T.R.; Cottler-Fox, M.; Cahill, R.; Pickle, L.W. 1991: Conditioning-related toxicity and acute graft-versus-host disease in patients given methotrexate/cyclosporine prophylaxis Bone Marrow Transplantation 7(3): 193-198
Gluckman, E.; Devergie, A.; Sohier, J.; Saurat, J.H. 1980: Graft-versus-host disease in recipients of syngeneic bone marrow Lancet 1(8162): 253-254
Smyth, L.A.; Witt, C.S.; Christiansen, F.T.; Herrmann, R.P.; Hollingsworth, P.N.; Townend, D.C.; Edward, E.; Dawkins, R.L. 1993: The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation Bone Marrow Transplantation 12(4): 351-355
Blazar, B.R.; Taylor, P.A.; Fitzsimmons, W.E.; Vallera, D.A. 1994: FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation Journal of Immunology 153(4): 1836-1846
Sullivan, K.M.; Siadak, M.F.; Witherspoon, R.P. 1990: Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation Transplantation Proceedings 22(3): 1336-1338
Dale, B.M.; Atkinson, K.; Kotasek, D.; Biggs, J.C.; Sage, R.E. 1989: Cyclosporine-induced graft vs host disease in two patients receiving syngeneic bone marrow transplants Transplantation Proceedings 21(5): 3816-3817
Michallet, M.; Corront, B.; Bosson, J.L.; Molina, L.; Peissel, B.; Maraninchi, D.; Reiffers, J.; Chabannon, C.; Gaspard, M.H.; Stoppa, A.M. 1991: Role of splenectomy in incidence and severity of acute graft-versus-host disease: a multicenter study of 157 patients Bone Marrow Transplantation 8(1): 13-17
Martin-Algarra, S.; Bishop, M.R.; Tarantolo, S.; Cowles, M.K.; Reed, E.; Anderson, J.R.; Vose, J.M.; Bierman, P.; Armitage, J.O.; Kessinger, A. 1995: Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis Experimental Hematology 23(14): 1503-1508
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Rosenkrantz, K.; Keever, C.; Bhimani, K.; Horvath, A.; Brochstein, J.; O'Reilly, R.; Dupont, B.; Flomenberg, N. 1990: Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiency Journal of Immunology 144(5): 1721-1728
Tsoi, M.S.; Mori, T.; Brkic, S.; Dobbs, S.; Gillis, S.; Santos, E.; Thomas, E.D.; Storb, R. 1984: Ineffective cellular interaction and interleukin 2 deficiency causing T cell defects in human allogeneic marrow recipients early after grafting and in those with chronic graft-versus-host disease Transplantation Proceedings 16(6): 1470-1472
Kahan, B.D.; Julian, B.A.; Pescovitz, M.D.; Vanrenterghem, Y.; Neylan, J. 1999: Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group Transplantation 68(10): 1526-1532
Ringdén, O.; Remberger, M.; Persson, U.; Ljungman, P.; Aldener, A.; Andström, E.; Aschan, J.; Bolme, P.; Dahllöf, G.; Dalianis, T. 1995: Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings Bone Marrow Transplantation 15(4): 619-625
Remberger, M.; Ringden, O.; Aschan, J.; Ljungman, P.; Lönnqvist, B.; Markling, L. 1994: Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients Transplantation Proceedings 26(3): 1829-1830
Hovdenes, J.; Solheim, B.G. 1995: Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(12): 1499-1501